Summary
Latest filing:
Fred A. Middleton files SEC Form 4 reports at CalciMedica, Inc. (CALC). 6 SEC Form 4 filings on record going back to 2024, most recently on 29 June 2026. Most recent open-market trade: bought $200K of CALC on 29 June 2026. Lifetime open-market purchases: $617K.
Recent transactions
11The latest 11 SEC Form 4 transactions reported by Fred A. Middleton.
Trading pattern
InsiderAlpha's records for Fred A. Middleton go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $123K (5 buys totaling $617K). The largest single buy on record is $326K of CALC in 2024. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Fred A. Middleton. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric W. Roberts - $341K in CALC purchases and sales on record
- Sanderling Venture Partners VI Co Investment Fund LP - $329K in CALC purchases and sales on record
- Robert N. Wilson - $213K in CALC purchases and sales on record
- A. Rachel Leheny - $85K in CALC purchases and sales on record
- Sudarshan Hebbar - $43K in CALC purchases and sales on record
- Kenneth A. Stauderman - $9K in CALC purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Fred A. Middleton?
Fred A. Middleton is a corporate insider of CalciMedica, Inc. (CALC). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Fred A. Middleton last file a Form 4?
The most recent primary Form 4 on record is dated 29 June 2026, one of 6 filings going back to 2024.
Has Fred A. Middleton been buying or selling stock?
Recorded transactions: 5 open-market purchases ($617K) and 0 open-market sales across all tracked filings.